Kaleido Biosciences KLDO

$ 0.29 -3.69%

Annual report 2021
added 12-23-2023

Kaleido Biosciences Income Statement 2011-2024 | KLDO

Annual Income Statement Kaleido Biosciences

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Market Cap	73.7 M	538 M	221 M	-	-	-	-	-	-	-	-
Shares	41.9 M	36 M	25.7 M	-	-	-	-	-	-	-	-
Historical Prices	1.76	14.9	8.58	-	-	-	-	-	-	-	-
Net Income	-90.3 M	-81.6 M	-86.3 M	-61.7 M	-27.6 M	-9.68 M	-	-	-	-	-
Revenue	1.1 M	975 K	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	975 K	-	-	-	-	-	-	-	-	-
Operating Income	-87.7 M	-78.9 M	-86.7 M	-60.7 M	-	-	-	-	-	-	-
Interest Expense	2.84 M	2.8 M	977 K	1 M	-	-	-	-	-	-	-
EBITDA	-85.3 M	-77.1 M	-85.4 M	-59.9 M	-26.7 M	-9.34 M	-	-	-	-	-
Operating Expenses	88.8 M	79.8 M	86.7 M	-	-	-	-	-	-	-	-
General and Administrative Expenses	21 M	23.9 M	22.4 M	18.6 M	6.04 M	1.57 M	-	-	-	-	-

All numbers in USD currency

Quarterly Income Statement Kaleido Biosciences

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Shares	-	-	-	-	42.6 M	42.6 M	42.5 M	39.7 M	36 M	35.6 M	31.9 M	30.3 M	30.1 M	29.9 M	29.7 M	13 M	5.79 M	5.15 M	4.81 M	4.74 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income	-	-	-	-	-	-23.1 M	-23.9 M	-23 M	-	-23.1 M	-18.9 M	-19.6 M	-	-22 M	-24.6 M	-20.2 M	-	-17.4 M	-12.3 M	-10.8 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Revenue	-	-	-	-	-	104 K	211 K	297 K	-	482 K	250 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cost of Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Income	-	-	-	-	-	-22.4 M	-23.2 M	-22.3 M	-	-22.4 M	-18.1 M	-19.1 M	-	-22.1 M	-25 M	-20.6 M	-	-17.3 M	-12.4 M	-10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest Expense	-	-	-	-	-	709 K	705 K	709 K	-	713 K	683 K	688 K	-	258 K	260 K	258 K	-	243 K	253 K	249 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
EBITDA	-	-	-	-	-	-21.8 M	-22.6 M	-21.8 M	-	-21.9 M	-17.8 M	-18.7 M	-	-21.8 M	-24.6 M	-20.3 M	-	-17.1 M	-12.2 M	-10.1 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Operating Expenses	-	-	-	-	-	22.5 M	23.4 M	22.6 M	-	22.9 M	18.4 M	19.1 M	-	22.1 M	25 M	20.6 M	-	17.3 M	12.4 M	10.2 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and Administrative Expenses	-	-	-	-	-	5.11 M	5.78 M	5.46 M	-	7.2 M	5.56 M	5.92 M	-	5.93 M	6.18 M	5.43 M	-	7.14 M	3.21 M	2.67 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency